Product: 20/20 Onsight is launching its Mobile Vision Pods (MVP) Top Line: A new delivery model to make clinical trials  more accessible for patients across the country.
Close Up: The model, called Mobile Vision Pods (MVP), utilizes a modular structure that provides clinical researchers with a temporary but full-service site to accommodate intense patient visit schedules. The customizable nature of the pods makes it easy for 20/20 Onsite to control the entire floor plan design—even the doors and windows—according to the needs and specifications of each clinical trial, the company said.
Vital Stats: The model is an ideal solution for clinical trials with a duration of at least three months or with a need to assess a large number of patients in a short window. Depending on the nature of the trial, 20/20 Onsite can configure the MVPs with multiple exam lanes and a waiting room in order to assess more patients at a time.
https://www.2020onsite.com/